Heterologous booster vaccination enhances antibody responses to SARS-CoV-2 by improving Tfh function and increasing B-cell clonotype SHM frequency
Yanli Song, Changgui Li(National Institutes for Food and Drug Control), Zhihui Yang(Ministry of Education), Ying Xie(The First Hospital of Kunming), Shuyan Li(University of Oklahoma Health Sciences Center), Qian He(National Institutes for Food and Drug Control), Jiaolei Wang(National Institutes for Food and Drug Control), Chunting Bao(National Institutes for Food and Drug Control), Yufang Sun(National Institutes for Food and Drug Control), Huijie Yang(Beijing Institute of Technology), Yaru Quan(National Institutes for Food and Drug Control)
Cited by 10
Related Papers
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
|Cell|2020|802
Restoring Immune Function of Tumor-Specific CD4+ T Cells during Recurrence of Melanoma
|The Journal of Immunology|2013|210
Prevention and Reversal of Atrial Fibrillation Inducibility and Autonomic Remodeling by Low-Level Vagosympathetic Nerve Stimulation
|Journal of the American College of Cardiology|2011|146